is mounjaro a glp 1 receptor agonist the Same as Ozempic GLP-1 drugs Ozempic, Zepbound, and

SeghieriMRebelosEGastaldelliAAstiarragaBDCasolaroABarsottiEet al

Indications for sitagliptin include use in type 2 diabetes as monotherapy or in combination with metformin or thiazolidinediones

Long-term follow-up after bariatric surgery in a national cohort

Does free fatty acid infusion impair insulin action also through an increase in oxidative stress

The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)

Dulaglutide, a newer once-weekly GLP-1 receptor agonist, significantly increased heart rate (2.8 bpm, 95% CI: 1.5-4.2) compared with placebo at the dose of 1.5 mg [95]